awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37878982-0D04CC4C-F100-4302-9FB1-7641DFC1D405
Q37878982-0D04CC4C-F100-4302-9FB1-7641DFC1D405
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37878982-0D04CC4C-F100-4302-9FB1-7641DFC1D405
Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?
P2860
Q37878982-0D04CC4C-F100-4302-9FB1-7641DFC1D405
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37878982-0D04CC4C-F100-4302-9FB1-7641DFC1D405
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c34e2cad844442c38e9e20cbe5aa043294c7107a
P2860
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Ear